Skip to nav Skip to content

Board of Directors

Facebook Twitter LinkedIn Email

Executive Committee 

preview-full-Alexander 2018.jpgBarbara D. Alexander, MD, MHS, FIDSA, President

Dr. Alexander is Professor of Medicine and Pathology at Duke University School of Medicine where she also serves as Director of Transplant Infectious Diseases Service; Head of Clinical Mycology Laboratory and Director of the Transplant Infectious Diseases Fellowship Program. She is principal investigator of the Duke University NIHT32-funded Transplant Infectious Diseases Interdisciplinary Research Training Program.

Dr. Alexander’s research interests include clinical and translational research related to infectious complications of solid organ and hematopoietic stem cell transplantation, with a particular interest in the prevention and rapid diagnosis of invasive fungal infections. She has served as Chair of the Clinical and Laboratory Standards Institute Subcommittee on Antifungal Susceptibility Tests, Associate Deputy Editor of the Clinical Infectious Diseases journal, consultant to the FDA Antimicrobial Drugs Advisory Committee, and as faculty mentor to the NIH T32-funded Tri-insitutional Molecular Mycology and Pathogenesis Training Program.

She has served IDSA on numerous committees, including the ID Training Program Directors Committee; the Education Committee, the Annual Meeting Program Committee, which she chaired in 2011; the Transplant ID & Compromised Hosts Working Group and the ID Recruitment Task Force. She also served on the Board of Directors from 2013-2016.

Daniel P McQuillen.jpgDaniel P McQuillen, MD, FIDSA, President-Elect

Dr. McQuillen is Senior Physician in the Division of Infectious Diseases at Beth Israel Lahey Health, Lahey Hospital & Medical Center, and Assistant Professor of Medicine, Tufts University School of Medicine. Dr. McQuillen has been an active member of IDSA for over two decades, serving a term on the Board of Directors and as a member and chair of the Society’s Clinical Affairs Committee and its Valuation Workgroup as well as the IDWeek Program Committee, focusing much of his time promoting the value of the ID specialist.

He is the co-author of three research papers supporting the value of ID. He is committed to addressing what he believes is one of the greatest challenges facing the specialty today: fair reimbursement for infectious diseases services. 

Carlos del Rio headshot.jpgCarlos del Rio, M.D., FIDSA, Vice President

Dr. del Rio is a Professor of Medicine at Emory University School of Medicine, Professor of Global Health and Epidemiology at the Rollins School of Public Health of Emory University and the Executive Associate Dean of Emory at Grady Health System. He is also Principal Investigator and Co-Director of the Emory Center for AIDS Research and Co-Principal Investigator of the Emory-CDC HIV Clinical Trials Unit and Emory Vaccine and Treatment Evaluation Unit. He has served the society throughout his career, including serving as Chair of IDSA’s HIV Medicine Association and as a past member of the IDSA Board.

He is an astute and experienced leader with a great deal of experience communicating about and implementing a strategic vision. He is deeply committed to resident and fellow education and the development of the next generation of ID and HIV leaders and is passionate about recruiting more underrepresented minorities into the field and eliminating gender disparities in salary and opportunities.

Angela M Caliendo, MD PHD.jpgAngela M Caliendo, MD PHD, FIDSA, Secretary

Dr. Caliendo is Professor and Executive Vice Chair in the Department of Medicine at Alpert Medical School of Brown University. Dr. Caliendo has been deeply involved with IDSA for many years. During her recent term as a board member, she was most proud of the Society’s focus on diversity, inclusion and equity and believes the commitment to these principles has led to a conscious effort to attract members with more diverse backgrounds, perspectives, and interests onto committees and into leadership positions.

Dr. Caliendo has a great deal of experience advocating for ID on Capitol Hill with IDSA as a board member and as a past chair of IDSA’s Diagnostics Committee and has played a pivotal role in transitioning IDSA into the leading voice for policies pertaining to antimicrobial resistance and regulation of diagnostic tests.

Helen W Boucher 2015_web.jpg

Helen W. Boucher, MD, FIDSA, Treasurer

Helen Boucher, M.D., FIDSA is chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and director of the Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR). She is also director of the Heart Transplant and Ventricular Assist Device Infectious Diseases Program at Tufts Medical Center and a professor of medicine at Tufts University School of Medicine.

Dr. Boucher’s clinical interests include infections in immunocompromised patients and S. aureus infections.  Her research interests focus on S. aureus and the development of new anti-infective agents.  She is the author or coauthor of numerous abstracts, chapters and peer-reviewed articles, which have been published in such journals as The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and The Annals of Internal Medicine; she is Associate Editor of Antimicrobial Agents and Chemotherapy.

She has been included in Best Doctors in America since 2009.   In 2011, Dr. Boucher was elected Fellow and Member of the Board of Directors of the Infectious Diseases Society of America.  In 2012, she was elected to the American Board of Internal Medicine Infectious Disease Exam Writing Committee and in 2014, to the American Board of Internal Medicine Infectious Diseases Subspecialty Board.

Dr. Boucher’s drug development experience includes participating in the global development and registration of voriconazole and daptomycin, including presentation at the FDA Advisory Committee and CHMP meetings.  She advises both small and large companies on antimicrobial drug development, advocates for increased research and development of new antimicrobial drugs, and teaches in the annual Tufts Center for Drug Development course.

In 2015 she was appointed to the Presidential Advisory Council on Combating Antibiotic-resistant Bacteria, and elected Treasurer of the Infectious Diseases Society of America.  She was awarded the IDSA Society Citation Award in October, 2015.  Dr. Boucher serves on the Board of Trustees of the Physicians of Tufts Medical Center and The College of the Holy Cross.

File Thomas 5x7.jpg Thomas File, Jr., MD, FIDSA, Immediate Past President

Thomas File, Jr., MD, FIDSA, is the Chair of the Infectious Disease Division and Co-Director of the Antimicrobial Stewardship Program at Summa Health, Akron, Ohio and is also the Professor of Medicine, Master Teacher and Chair of the Infectious Disease Section of the Northeast Ohio Medical University.

Dr. File’s research interests include randomized clinical trials for safety and efficacy of new antimicrobials, community-acquired pneumonia and the impact of new diagnostics and antimicrobial stewardship on patient outcomes. He is very involved in antimicrobial stewardship and his institution has been designated as an IDSA Antimicrobial Stewardship Centers of Excellence.

Dr. File is very active in IDSA having served on several committees such as the IDSA/National Foundation for Infectious Diseases (NFID) Joint Research Awards Committee, Clinical Subcommittee of Pulmonary Diseases, and the Practice Guidelines Committee. He was also the Chair of the Practice Guidelines Committee from 2005-2008 and a member of the Board of IDSA from 2008-2011. Dr. File also received the Watanakunakorn Clinician Award from IDSA in 2013.

As an advocate for using IDSA’s Clinical Guidelines for the diagnosis and management of infectious diseases, Dr. File also participated in several panels like the Influenza Guideline panel, the Sinusitis Guideline panel, the Community-Acquired Pneumonia Guideline panel and the Hospital-Associated Guideline panel.

After graduating from the University of Michigan School of Medicine, Dr. File became an intern and Resident in Internal Medicine at Riverside Methodist Hospital in Columbus, Ohio. He continued his studies as a Fellow in Infectious Diseases and earned his MSc in Medical Microbiology at Ohio State University.


Cesar A. Arias, M.D., MS, PhD, FIDSA
UTHealth McGovern Medical School
Houston, Texas
Rana Chakraborty, M.D., MSc, PhD, FIDSA
Mayo Clinic Alix School of Medicine and Mayo Clinic
Rochester, Minneapolis
Jeffrey Duchin, MD, FIDSA 
Public Health – Seattle & King County
University of Washington, Seattle
Kimberly E Hanson, MD
University of Utah Division of Infectious Diseases
Salt Lake City, Utah
John B Lynch, III, MD, MPH, FIDSA
Harborview Medical Center and University of Washington
Seattle, Washington
Ann MacIntyre, DO, MHS, FIDSA
Private Practice
Miami, Florida
Jasmine Marcelin, M.D., FACP, FIDSA
University of Nebraska Medical Center 
Lincoln, Nebraska 
Jeanne Marrazzo MD, MPH, FIDSA
University of Alabama, Birmingham
Birmingham, Alabama
Wendy Armstrong, MD, FIDSA, HIVMA Representative
Emory University 
Decatur, Georgia

Paul W. Spearman, MD, FIDSA, PIDS Liaison
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Infectious Diseases Society of America

Arlington, VA 


This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.